NCT06862843

Brief Summary

The proposed study is part of a PNRR 2022 project (call "Non-Communicable Chronic Diseases (NCDs) with high impact on healthcare and social assistance systems," currently awaiting funding response) and represents the continuation of an observational clinical study named TRANSMIC, approved by the pediatric ethics committee of the Tuscany region. TRANSMIC was an integral part of a European research project within the joint programming initiative (JPI), under the HDHL-INTIMIC theme: "A Healthy Diet for a Healthy Life," aimed at understanding the cause-effect relationships between diet, gut microbiome, and human health. Understanding the role of diet in inflammatory bowel diseases (IBD) and exploring its role in autoimmune inflammatory conditions with joint manifestations, such as JIA, provides additional insights into the development, progression, and management of these conditions, opening new horizons for the use of dietary treatments in preventing these inflammatory conditions.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2024

Geographic Reach
1 country

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 7, 2024

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

February 25, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 6, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2025

Completed
Last Updated

March 6, 2025

Status Verified

February 1, 2025

Enrollment Period

1.3 years

First QC Date

February 25, 2025

Last Update Submit

March 3, 2025

Conditions

Keywords

JIADietary habitsCDUCIBD

Outcome Measures

Primary Outcomes (1)

  • 3-days food diary, kidmed and medi-lite scores

    After two weeks

Secondary Outcomes (1)

  • Percentage of families with microbiota alteration

    After 6 months

Study Arms (2)

Case group

Families with at least a member affected with JIA or IBD (UC or CD)

Other: Collecting questionnaires and biological samples

Control group

Families with all healty components

Other: Collecting questionnaires and biological samples

Interventions

For each family member will be collected a 3-days food diary, a food frequencies questionnaire and a questionnaire assessing the adherence to the mediterranean diet. Additionally, a blood sample for trascriptomic analysis and a fecal sample for gut microbiota analysis will be collected

Case groupControl group

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Cases: Families consisting of father, mother, and children aged between 0 and 18 years, in good health, with at least one member (child or adult) affected by IBD (Crohn's disease or ulcerative colitis), and families with a child affected by JIA. Controls: Healthy families consisting of father, mother, and children aged between 0 and 18 years, in good health, and not affected by chronic inflammatory bowel diseases or any chronic autoimmune inflammatory diseases.

You may qualify if:

  • For families with at least one child/adult affected by IBD/JIA:
  • Father and mother with children aged between 0-18 years, in good health.
  • At least one adult or one child affected by IBD, or a child affected by JIA, regardless of ongoing therapy and without distinction of disease severity or activity.
  • For healthy families:
  • \- Father and mother with children aged between 0-18 years, in good health and not affected by chronic inflammatory bowel diseases or chronic autoimmune inflammatory diseases in general.

You may not qualify if:

  • For subjects affected by IBD:
  • Monogenic disease
  • Children with an ileostomy or who have undergone a colectomy
  • For subjects affected by JIA:
  • For healthy subjects:
  • \- Any chronic inflammatory bowel disease, autoimmune disease, or ongoing infectious diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

AOU Meyer IRCCS

Florence, Italy, Italy

RECRUITING

Università La Sapienza di Roma

Roma, Roma, 00185, Italy

RECRUITING

Università di Foggia

Foggia, Italy

RECRUITING

Ospedale Villa Sofia Cervello, Università di Palermo

Palermo, Italy

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Blood samples Fecal samples

MeSH Terms

Conditions

Arthritis, JuvenileCrohn DiseaseColitis, UlcerativeFeeding Behavior

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System DiseasesInflammatory Bowel DiseasesGastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal DiseasesColitisColonic DiseasesBehavior, AnimalBehavior

Central Study Contacts

Paolo Lionetti, MD, PhD, Ordinary Professor

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 25, 2025

First Posted

March 6, 2025

Study Start

February 7, 2024

Primary Completion

May 15, 2025

Study Completion

November 15, 2025

Last Updated

March 6, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations